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Abstract—The endometrium is the inner lining of the uterus.
Following speciﬁc cyclic hormonal stimulation, endometrial
stromal ﬁbroblasts (stroma) and vascular endothelial cells
exhibit morphological and biochemical changes to support
embryo implantation and regulate vascular function, respec-
tively.Herein, we integrated a resin-based porousmembrane in
a dual chamber microﬂuidic device in polydimethylsiloxane
that allows long term in vitro co-culture of human endometrial
stromal and endothelial cells. This transparent, 2-lm porous
membrane separates the two chambers, allows for the diffusion
of small molecules and enables high resolution bright ﬁeld and
ﬂuorescent imaging. Within our primary human co-culture
model of stromal and endothelial cells, we simulated the
temporal hormone changes occurring during an idealized 28-
daymenstrual cycle.We observed the successful differentiation
of stroma into functional decidual cells, determined by mor-
phology as well as biochemically as measured by increased
production of prolactin. By controlling the microﬂuidic prop-
erties of the device, we additionally found that shear stress
forces promoted cytoskeleton alignment and tight junction
formation in the endothelial layer. Finally, we demonstrated
that the endometrial perivascular stroma model was sustain-
able for up to 4 weeks, remained sensitive to steroids and is
suitable for quantitative biochemical analysis. Future utiliza-
tion of this device will allow the direct evaluation of paracrine
and endocrine crosstalk between these two cell types as well as
studies of immunological events associated with normal vs.
disease-related endometrial microenvironments.
Keywords—Endometrium, Stroma, Organs-on-a-chip, Mi-
croﬂuidic, Porous membrane.
INTRODUCTION
The female reproductive tract is composed of
interactive organs, including uterus and ovaries that
are physiologically regulated by endocrine signals at a
spatial–temporal level.14 The endometrium lines the
inner cavity of the uterus and is the primary maternal
tissue responsible for establishing embryo implantation
and the successful maintenance of pregnancy.2 Somatic
cell numbers and immune cell ratios within the en-
dometrium vary signiﬁcantly across each phase of the
menstrual cycle. However, histologic analysis of the
cycling endometrium consistently reveals luminal and
glandular epithelial cells supported by specialized
reticular stromal ﬁbroblasts (stroma), a vascular sys-
tem and a dynamic ﬂux of immune cells39 (Fig. 1).
Endometrial tissue homeostasis, cellular prolifera-
tion, metabolism and reproductive function are medi-
ated by the crosstalk between these cell types through
paracrine and endocrine pathways.3,9,11,31–33 The
cyclical changes of ovarian sex steroids production,
oestrogen and progesterone, dictate timing and func-
tional capabilities of the endometrium to support em-
bryo implantation. These steroids account for the
distinct phases of the menstrual cycle by driving cell-
speciﬁc morphological and biochemical changes (as
depicted in Fig. 1d).
In the endometrium of humans and some other
primates,20,37,42 during the secretory phase of a non-
pregnant menstrual cycle, increasing levels of ovarian
progesterone trigger a partial, spontaneous decidual-
ization process within the stroma.
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In all women, the morphological and biochemical
diﬀerentiation of stroma into specialized decidual cells
is clinically recognized as being critical for the suc-
cessful establishment and maintenance of pregnancy to
term. Decidualized stroma exhibit an epithelial-like
cuboidal morphology and develop the biochemical
capacity to release several pro-gestational molecules
including prolactin and insulin-like growth factor
binding protein-1. Histological evidence of secretory
phase decidualization has been observed to originate in
those regions directly surrounding the vasculature
(Fig. 1b). While this basic, visual observation is well
accepted in the ﬁeld, the degree to which paracrine
signalling mechanisms between vascular cells and
adjacent specialized ﬁbroblasts drives early decidual-
ization at this speciﬁc site has not yet been determined.
At present, a lack of appropriate in vitro models of
human endometrial cells that allow analysis of poten-
tial interactions between key cell types necessary to
support the successful establishment and maintenance
of pregnancy hinders progress in understanding this
critically important aspect of reproductive tract func-
tion.2,12
Many researchers, including our group, have
demonstrated an important role for stromal-epithelial
cross talk in normal endometrial function while dys-
regulated cell–cell communication is associated with
numerous disease processes11,24,31,40; however, the
interaction between stroma and their adjacent vascular
endothelium has received less investigative attention.1
While steroid hormone receptors are largely concen-
trated in endometrial stromal and epithelial cells
(Fig. 1d), it is equally true that the proliferative en-
dometrium becomes increasingly thicker due to
endometrial vascularization, as spiral arteries grow
within the stroma in response to increasing levels of
oestrogen. In regards to this biological relationship,
Albrecht et al.1 co-cultured human endometrial so-
matic cells (i.e. epithelial and stromal cells) with
myometrial microvascular endothelial cells using a
transwell assay and observed an increase in endothelial
tube formation and vascular endothelial growth factor
production under the inﬂuence of oestrogen.1 Together
with established histological observations, Albrecht’s
in vitro study strongly suggests that interactions
between endothelial and stromal cells occur via active
paracrine communication.
In relation to the culture system described herein,
the possibility to precisely recreate and visualize mor-
phological and functional changes in a microﬂuidic
model will be critical to better understand not only
oestrogen action, but also progesterone-directed com-
munication between these speciﬁc cell types during the
second half of the human menstrual cycle. In addition
to the cyclic oestrogen and progesterone mediated
events described above, it is also important to note that
biologically signiﬁcant changes also occur in relation
to the immunomodulatory function of endothelial cells
at the end of the secretory phase of the menstrual
cycle.21–23,46
A more physiologic model system of the perivas-
cular stroma should provide not only a better basic
knowledge of normal steroid-mediated endometrial
function but also holds promise to reveal how altered
patterns of cell–cell communication promotes the
pathogenesis of diseases, including breakthrough
bleeding, infertility, menorrhagia, endometriosis,
pregnancy disorders and endometrial cancer.20,21
Unfortunately, most in vitro models fail to mimic the
in vivo physiological conditions that the endothelium
experiences, including bidirectional paracrine crosstalk
between cells and hemodynamic forces. Moreover,
current in vitro models do not allow for high resolution
real-time examination of functionally signiﬁcant mor-
phological changes. Current transwell assays largely
enable modelling of speciﬁc cell barriers in human
organs, such as epithelium4 or endothelium,36 with
minimal capability to mimic and control the hemody-
namic ﬂow conditions observed in the vasculature.
Several in vivo and in vitro studies have deﬁned the role
of hemodynamic forces in the regulation of vascular
function35,47: once exposed to shear stress from the
continuous blood circulation, endothelial cells undergo
cytoskeletal remodelling (from cobblestone shaped in
static conditions to elongated cell body in the direction
of ﬂow in dynamic conditions)10 and become func-
tionally different compared to cells cultured in static
conditions.32,33
Multi-compartmental 3D microﬂuidic cell culture
devices, so called ‘‘Organs-on-a-Chip’’ (OoC) have
been introduced to address limitations of in vitro
modelling.6,8,9,13,15,25,26,28,30 These models represent
robust compartmentalized, heterogeneous cell culture
systems to simulate the physiology and anatomy of
human organs and thus should enhance our under-
standing of in vivo mechanisms that are otherwise
difﬁcult to study. Via microﬂuidic compartmentaliza-
tion, the role of speciﬁc cell types can be identiﬁed as
well as the cell-speciﬁc effects of biomechanical forces
(e.g. shear stress) and chemical (steroid stimulation)
cues that are externally introduced and controlled in
the system. Key analytical functions of OoC include
real-time imaging of a cell culture, maintenance of long
term cultures (a minimum of 4 weeks), non-invasive
selective staining and the analysis of secretion and
metabolism of the individual cell types by sampling
spent media from each compartment. Additionally,
while commonly used transwell inserts rely on polye-
ster and polycarbonate membranes that are opaque in
bright ﬁeld or may contribute to high auto ﬂuores-
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cence, PDMS technology results a completely trans-
parent apparatus which does not limit high resolution
imaging analysis and thus enhances data interpreta-
tion. An important advantage of the OoC is the
reduction of the total media volumes required for cell
culture thus limiting dilution of nutrients and selected
test molecules within the system: these conditions may
favour the speciﬁc study of the paracrine signalling
between the different cell types.45
To better understand the interactive role of the
perivascular stroma in the human endometrium, we
have designed and developed a dual chamber
microﬂuidic device that integrates a resin-based
microfabricated porous membrane and allows long
term co-culture of human primary umbilical vein
endothelial cells (HUVECs) and endometrial stroma.
With this OoC model, our group and other researchers
will be able to accurately examine and analyse mor-
phological and biochemical aspects of the interactive
roles of endometrial stromal and endothelial cells un-
der the inﬂuence of sex steroid regulation.
MATERIALS AND METHODS
Fabrication of the 1002F Membranes
A transparent, semi-permeable membrane was used
in the device to separate the cell types within two
microﬂuidic chambers. The membranes are fabricated
by using a photolithographic method29,41 with bio-
compatible resin, EPON 1002F (Miller-Stephenson,
Sylmar, CA). Brieﬂy, the 1002F resin and a photoini-
tiator (UVI-9676, Dow Chemical, USA) were dis-
solved in c-butyrolactone (GBL, Sigma Aldrich, USA)
at a ratio of 10:1:10 by weight. A 100-mm silicon wafer
was treated with plasma (2 min, O2, 13.3 Pa) and
coated with a sacriﬁcial layer of soap (2% Micro-90,
International Products, Burlington, NJ, USA). An
FIGURE 1. The human endometrium. (a) A schematic representation of the human female reproductive tract. (b) A histological
image of the endometrial micro-environment in the secretory phase of the menstrual cycle shows decidualization of the stromal
fibroblasts in regions surrounding endothelial vessels (original magnification 3400). (c) False colouring of peripheral leukocytes,
and endothelial cells of the endometrial perivascular stroma (original magnification 31000) (Haematoxylin and eosin staining, in b
and c). (d) A schematic summary of the ovarian hormones changes during the endometrial cycle: the menstrual cycle can vary
widely among individual women, but an idealized length is generally considered to be 28 days. During each menstrual cycle, the
endometrium undergoes a proliferative phase (6–14 days) when oestrogen concentrations rise up to a level capable of triggering
ovulation and the subsequent development of the corpus luteum. In the secretory phase (days 15–28), production of ovarian
progesterone promotes endometrial differentiation. The endometrium later experiences a sharp withdrawal of ovarian sex steroids,
resulting in an inflammatory cascade that leads to the shedding of the endometrial tissue over 3–6 days, a process known as
menstruation and which marks the beginning of a new cycle (days 1–6).16,18–20,39
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8-lm layer of 1002F (diluted 1:1 in GBL) was de-
posited by spin coating and then soft baked. The wa-
fers were then exposed through a 125-mm chromium–
quartz photomask (10 mW/cm2, 14 s). After a post-
exposure bake, the patterned resist was developed in
propylene glycol methyl ether acetate. Each membrane
is patterned with a 6.5 9 6.5 mm2 array of 2-lm pores
enclosed within a 15-mm diameter circle.
PDMS Layer Design and Fabrication
The device was assembled using two 4.75 mm by
6.2 mm microﬂuidic chambers separated by a semi-
permeable 1002F membrane. The complete device was
fabricated by soft lithography17 in polydimethylsilox-
ane (PDMS, Sylgard 184, Dow Corning, MI, USA)
(Fig. 2) as summarized in Fig. 2.
Assembly of the Two-Chambers Platform
The 1002F membranes were released from the sili-
con master by dissolving the sacriﬁcial Micro-90 soap
layer. The membranes were carefully removed and
inspected for quality prior to bonding. After release,
the membranes were kept in sterile H2O to remove
residual soap and to prevent drying. The top PDMS
layer and the 1002F membrane were then oxygen-
plasma treated (600 mTorr, 100 W, 45 s) and bonded
together. Since both PDMS and 1002F are optically
transparent, alignment of various components was
completed under a stereomicroscope. The second layer
was then bonded with the same method on the 1002F
membrane orthogonally to the top PDMS layer.
Oxygen-plasma treatment renders the exposed sur-
faces hydrophilic. Hence, the assembled devices were
immediately ﬁlled with sterile DI H2O and stored at
4C until used. For static experiments, 500 lL cloning
cylinders (Fisher Scientiﬁc, Pittsburgh, PA, USA) were
bonded with liquid PDMS to the inlet/outlet regions of
each channel to form small reservoirs for the cell
media.
Acquisition of Human Tissues
The Vanderbilt University Institutional Review
Board approved the procedures for tissue acquisition,
performed only after patients gave informed consent.
Primary human umbilical vein endothelial cells (HU-
VECs) were isolated from umbilical cord,5 obtained
from de-identiﬁed term placenta collected from
patients who underwent elective caesarean section
between 37 and 39 weeks of gestation. For this phase
of establishment, optimization and characterization of
the OoC, HUVECS were selected since they represent
FIGURE 2. Fabrication process: (1) Mylar mask (40,000 dpi, Infinite Graphics Incorporated, MN, USA): the design for a single
chamber includes the 35 circular pillars (diameter 100 lm), scale bar 1 mm. (2) Fabrication of SU 8 master by photolithography: a
bas-relief master was fabricated in a Class 100 clean room with SU8-2100 negative photoresist (Microchem, MA, USA). 4¢¢ silicon
wafers were spin coated with SU8 (30 s at 2000 rpm, final thickness ~150 lm). The resist layer was exposed to UV light through the
mask and finally processed with SU-8 developer to removed unexposed resist. (3) Liquid PDMS (prepolymer to curing agent ratio
10:1) was cast and cured on the SU8 master to obtain two equal layers. (4) Cured PDMS layers were demoulded, and ports to
access the microfluidic chambers were opened by punching 1/16¢¢ holes in the top layer with a stainless steel round punch (Integra
Myltex, NJ, USA). (5) The porous membrane was plasma activated and sandwiched between to PDMS layers. Soft, post-exposure
and final hard baking steps were done following datasheet indications.
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the most common model based on human derived
primary endothelial cells.34 After isolation, we consis-
tently observed ‡95% purity of endothelial cells, vali-
dated morphologically and by immunoﬂuorescent
staining for CD31 (DAKO, USA) before loading in the
devices. Cells were cultured in EBM-2 medium sup-
plemented with EGMTM-2 Single Quot growth fac-
tors (Lonza, USA), maintained at 37C in a saturated
humidity atmosphere containing 95% air/5% CO2,
and they were sub-cultured before reaching 60–70%
conﬂuence (approximately every 2 days) up to passage
5.
For acquisition of endometrial stroma, surgically
excised uterine tissues were collected from consented
donors (ages 18–45) exhibiting predictable menstrual
cycles and undergoing a hysterectomy for benign
leiomyoma not associated with any additional inﬂam-
matory ovarian or endometrial disease. Endometrial
stroma were isolated by enzymatic digestion and ﬁlter
separation.40 As with our endothelial cell preparation,
the purity of the stroma isolation was above 95% and
was quantiﬁed by morphological assessment and pos-
itive staining for vimentin as previously described.40
Stroma were maintained in phenol red-free DMEM/
F-12 with 10% charcoal-stripped calf serum, 1 nM 17-
b oestradiol (Sigma Aldrich, USA) and 19 antibiotic–
antimycotic solution (stromal complete growth med-
ium). As required for experimental objectives, some
stroma cultures received treatments with 0.5 mM
medroxyprogesterone acetate (MPA, Sigma Aldrich,
USA) and/or 8-bromoadenosine-3¢,5¢-cyclic
monophosphate (cAMP, 0.5 mM, Sigma Aldrich,
USA) to induce a decidualization response over a
period of 14 days.
Cell Culture and Maintenance in Device
Isolated stromal and endometrial cells were initially
expanded within 75 mm ﬂasks before transfer to our
microﬂuidic devices. Upon achieving approximately
80% conﬂuent monolayers, both endothelial and
stromal cells were separately trypsinized, pelleted by
centrifugation (220 rcf), resuspended in full medium
(1 9 106 cells/mL) and subsequently loaded into each
chamber using a 1 mL syringe. To enhance cell adhe-
sion inside the device we utilized a thin coating of 1:50
dilution of Matrigel (BD Bioscience, USA) on both
chambers to provide an extracellular matrix substrate.
The cells were allowed to adhere for a minimum of
30 min inside the incubator. 300 lL of EBM-2 medium
or complete growth medium, were added to the
endothelial top chamber or stromal bottom chamber,
respectively. Spent media from the reservoirs were
collected and replaced daily with fresh media
throughout all static experiments.
For dynamic ﬂow experiments, the endothelial
chamber was perfused by using a syringe pump (Pi-
coPlus, Harvard Apparatus, Cambridge, USA) and by
connecting Tygon tubing (Cole-Parmer) directly into
the inlet port of the device. Shear stress conditions
were induced when the cells reached 60% conﬂuence.
The ﬁnal value of 1 lL/min was deﬁned with this
protocol as minimal value for the cells to form a tight
and reoriented endothelium. The stroma were main-
tained under the same static culture conditions through
all experiments. Wall shear stress in the center of the
chamber (approximately 6 9 1023 dyn s cm22) was
calculated as in Sung et al.44 treating the chamber as a
relatively ﬂat channel (with width  height). Bubble
formation was limited by loading the microﬂuidic
chambers with DI water immediately after plasma
treatment and by equalizing the temperature of the
media in the syringe and inside the device before
starting the perfusion.
Fluorescence Imaging
Mouse monoclonal anti human CD-31 primary
antibody (DAKO, USA) was used at a 1:50 dilution
and goat anti-mouse IgG Cy3 conjugate (Jackson
Immuno Research, USA) was used as the secondary
antibody (1:200). Tight junction expression of zona
occludens-1 (ZO-1) was measured with a mouse anti-
human FITC-conjugated antibody (1:50, Invitrogen,
USA). A rabbit antibody against human vimentin
(1:200, Abcam, USA) was used with a FITC conju-
gated goat anti-rabbit antibody as a secondary anti-
body (1:100, Jackson ImmunoResearch, USA).
Standard ﬁxation and immunoﬂuorescence staining
protocols were performed as described in the product
datasheet. The cell nuclei were stained with 4¢6-di-
amidino-2-phenylindole (DAPI, Sigma Aldrich) for
1 min and then washed with 1X PBS.
Membrane Permeability Assay
A 3 mL syringe was ﬁlled with a 2.5 mg/mL solu-
tion of FITC-dextran (150 kDa MW, Sigma Aldrich,
USA) and mounted on a syringe pump. The syringe
was connected to the top chamber with microbore
tubing, while 200 lL of 1X PBS were added to the
outlet reservoir and to the inlet and outlet of the bot-
tom chamber. Perfusion was run at 2.5 lL/min.
100 lL samples were collected from each of the
reservoirs and replaced with 100 lL of PBS at 1, 2 and
3 h intervals. Fluorescence intensity in the collected
eﬄuent was measured using a ﬂuorescence microplate
reader (GloMax Multimode Readers, Promega) at
470 nm excitation and 520–550 nm emission range
(details in Supplemental Material).
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Eﬄuent Collection and Protein Measurement
The devices were cultured initially for 14 days in
either complete growth medium, or complete EBM-2
medium supplemented with oestradiol (1 nM) until
both cell monolayers reached 80% conﬂuence. The
complete growth medium for the stromal chamber was
then supplemented with MPA (0.5 nM) and media was
collected and changed daily (300 lL) for an additional
14 days from both inlet and outlet. Collected eﬄuents
were then analysed by measuring prolactin production,
a marker of decidualization, using an enzyme-linked
immunosorbent assay (ELISA Duoset, R&D systems).
The ELISA was performed according to the manu-
facturer’s instructions using 50 lL samples. The plate
was read using an absorbance microplate reader
(GloMax Multimode Readers, Promega). The results
are representative of three different experiments. Due
to the patient-related variability among experiments,
we normalized prolactin concentration to the minimal
mean prolactin production at day 2. Statistical analysis
was performed by a 2 way ANOVA using a Bonferroni
correction. Statistical signiﬁcance was calculated as
p< 0.05.
RESULTS
Fabrication of a Dual-Chamber Microﬂuidic Device
with a High-Resolution Porous Membrane
As noted above, the ability of researchers to under-
stand the intercellular paracrine interactions that regu-
late endometrial function within the perivascular
microenvironment is limited by a lack of an appropriate
model to accurately recreate the perfusion characteristics
and physical compartmentalization at this tissue site. To
overcome these constraints, we designed a microﬂuidic
device and integrated a transparent semipermeable
membrane (Fig. 3) to model the endometrial vascular
interface between endothelial and endometrial stromal
cells that mediate critical reproductive processes.
The device consists of 2 orthogonal microﬂuidic
chambers, each one providing 29.45 mm2 of cell
FIGURE 3. Design and characterization of the dual chamber microfluidic device with a high resolution membrane. (a) Schematic
of the two chambers design. (b) A photograph of the assembled PDMS device with four reservoirs corresponding to inlets and
outlets: the porous membrane appears translucent. (c) A top view of a chamber with bonded porous membrane: the border of the
porous region on the top can be distinguished by the lower non-porous region, and thus easily aligned with the chamber wall and
the circular pillars; one of the 5 pillars appears on the top, in the exact center of the chamber. (d) Top view image of the 1002F
membrane with 10% porosity inside device. The porosity is calculated as the ratio of the combined area of the pores to the total
area of the patterned region. (e) A cross section of the assembled device: the two chambers and the cylindrical pillars can be
visualized as well as the green coloured 1002F membrane (enhanced background fluorescence was used to visualize the mem-
brane in green).
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growth area and a volume of 4.7 lL. The chambers are
divided by the 1002F resin-based membrane, and
sealed by plasma bonding. The 1002F membrane is
biocompatible, has a 6-lm thickness (DekTak3 surface
proﬁlometer) and 2-lm circular pores that allow sol-
uble factor communication and cellular contact
between cells cultured on the two sides.29 The pat-
terned membrane fully spans the chamber to provide a
compartmentalized region, suitable for cell co-culture
assays (Fig. 3). Due to the aspect ratio of the ﬂuidic
chamber, the ﬂexibility of the membrane and the use of
automated perfusion of the endothelial chamber, we
incorporated a series of pillars within the chambers
that provide structural support to the membrane.
While it is important to note that these pillars may
alter dynamic ﬂow proﬁle inside the chamber, we al-
ways observed homogeneous cell distribution during
loading and uniform proliferation and polarization
throughout the chamber (see next sections). Further-
more, the density and size of membrane pores does not
affect the cell loading and the ﬂow dynamic inside the
device. Repetitive loading of cells in the two chambers
did not show leakage of cells through the pores (since
the 2-lm diameter is smaller than the size of the indi-
vidual cell).
The 1002F membrane is transparent and the porous
region can be distinguished from non-porous one
(Fig. 3c). This simpliﬁes layer alignment during device
assembly and aids in determining the cell density ratios
following device seeding. Being both PDMS and 1002F
membrane transparent, we are able to characterize real
time cell maintenance inside the device as described in
detail below and perform low background
immunoﬂuorescent imaging.
Characterization of the Microﬂuidic Model of the
Endometrial Perivascular Stroma
Little is known about the role of the vascular
endothelium in regulating endometrial reproductive
processes due to a lack of adequate models that
physiologically mimic the in vivo characteristics of
human tissue. To evaluate the cellular growth inside
the device, we seeded primary human endothelial cells
and endometrial stromal cells in the top and bottom
chambers of the device, respectively. Both cell types
were loaded simultaneously (1 9 106 cells/mL), lead-
ing to a ﬁnal cell seeding density of 5000 cells/mm2.
Static culture conditions inside the OoC were main-
tained for up to 28 days, corresponding to the length
of an idealized menstrual cycle.
In order to conﬁrm the compartmentalization of the
two cell types, the vascular monolayer was selectively
stained for the endothelial cell marker CD31, while the
stromal compartment was stained for vimentin
(Figs. 4b and 4c). We observed a clear compartmen-
talization of the two cell types throughout the device.
Each cell type was observed to adopt characteristic
morphologies similar to those seen in cells cultured on
traditional polystyrene cell culture dishes, with distinct
cobblestone morphology exhibited by the endothelial
monolayer and a conﬂuent layer of the stroma
ﬁbroblasts that initially exhibited a striated morphol-
ogy prior to decidualization (Fig. S2). Furthermore,
there were no distinguishable morphological differ-
ences in the endothelial layer between porous and non-
porous regions of the membrane and was conﬁrmed by
CD31 immunoﬂuorescent staining (Fig. S1a). Over
time, endothelial cells were able to colonize and
establish a conﬂuent layer at the top and at the bottom
of the chamber (Fig. S2d).
Validation of the Endothelial Monolayer Shear Stress
Polarization, Actin Cytoskeleton Realignment
and Barrier Function
Vascular blood ﬂow is an essential characteristic of
endothelial cell biology and thus in order to appro-
priately mimic the ﬂuid dynamic condition of the
perivascular endometrium within our OoC, only the
endothelial cells were dynamically perfused, while the
stroma cells were cultured under static conditions. We
utilized morphological polarization as a marker of
culture conditions exhibiting physiologic shear stress.
The endothelial cells were allowed to proliferate to
conﬂuence in full medium in static conditions (Fig. 5a)
and subsequently exposed to 1 lL/min ﬂow for a
minimum of 4 days (Fig. 5b). The stroma were kept in
static conditions since this cell type is not affected by
direct shear stress in physiological conditions within
the endometrium.
Tight junction formation, observed by staining ZO-
1, was positively identiﬁed in both conditions, but only
the shear stressed monolayers formed clear parallel
margins around the cell body. These cells showed
polarization and changes in cell shape from polygonal
to ellipsoidal (Fig. 5b), as result of alterations in the
F-actin ﬁlaments and reorientation of stress ﬁbers in
the cytoskeletal structure. As a proof of principle, long
term culture of a conﬂuent endothelial layer was
maintained under continuous perfusion for more than
24 days (Supplemental Material). The dual-chamber
device also permits assaying the functional integrity of
the endothelial monolayer in forming a barrier to dif-
fusive transport. We evaluated the permeability of the
endothelial monolayer by measuring the transfer of
ﬂuorescently labelled dextran (150 kD MW) between
the two chambers of the device. Compared to an
unpopulated device, there was a signiﬁcant reduction
in the permeability coefﬁcient of the membrane once
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the endothelial layer was conﬂuent (Fig. 6). These
ﬁndings conﬁrm both the permeability of the mem-
brane and the establishment of a conﬂuent and tight
endothelial monolayer working as barrier to macro-
molecule transport. The comparison of single cultures
of stromal cells in the bottom chamber, compared to
co-culture of both endothelial and stromal cells, sug-
gests that it is the endothelium that is promoting the
barrier capabilities (Fig. S3).
Validation of Reproductive Function of the Endometrial
Perivascular Specialized Stromal Fibroblasts
Endometrial stromal ﬁbroblasts are specialized cells,
uniquely diﬀerent from other types of mesenchymal
cells in the human body. Reﬂecting their fundamental
role in the endocrine-mediated function of the en-
dometrium, they express both oestrogen and proges-
terone receptors and are highly responsive to the
ovarian sex steroids changes across the menstrual
cycle.16 Under the inﬂuence of progesterone during the
secretory phase of the menstrual cycle, stromal
ﬁbroblasts begin the process of decidualization. In
seminal histologic papers, Noyes et al. ﬁrst identiﬁed
the process of decidualization as morphological chan-
ges in stromal cells from the typical spindly shaped
ﬁbroblast to a cuboidal and glycogen rich decidual
cells.39 In addition, biochemical changes within the
differentiating stromal cells include the active secretion
of multiple progesterone-induced proteins that accu-
rately serve as biomarkers of the decidualization pro-
cess.7 Therefore, to validate both the physiological
function and the sensitivity of our microﬂuidic
perivascular stroma co-culture model, we measured the
capability of the stromal cells to decidualize when
stimulated by MPA, a synthetic progestin that exhibits
more stability under culture conditions than natural
progesterone. An idealized, complete physiological
menstrual cycle was simulated, by supplementing the
cell culture medium for the ﬁrst 2 weeks with oestra-
diol alone (as in the proliferative phase, Fig. 7a), and
subsequently with oestradiol and MPA for the fol-
lowing 2 weeks (as in the secretory phase, Fig. 7b).
A shift in the morphology of the stromal cells toward
a round and cuboidal shape was observed after 10 days
of MPA treatment (Fig. 7b) as expected from other
in vitro studies.4,20 For a quantitative analysis of bio-
chemical markers of decidualization in response to dif-
FIGURE 4. Characterization of co-culture of endometrial stromal fibroblasts (stroma) and HUVECs in the two-chamber device. (a)
Schematic of the perivascular stroma model. (b) Characterization of compartmentalization and morphology: the stromal cells were
cultured in the lower chamber and stained for vimentin (in green), while HUVECs were cultured in the top chamber and stained for
CD31 (in red) (inset, 3100). (c) Stroma compartment showing the confluent layer of cells. (d) Endothelial compartment with
confluent layer of CD31 stained HUVECs. (e) By merging the three channels (DAPI, FITC, CY5) it is possible to visualize the identity
of each cell layer growing within the two compartments. As a consequence of the circular pillars (pointed by arrows), it is possible
to visualize a single cell type at a time (DAPI for nuclei staining in blue, 340 for c, d, e). Scale bars 5 400 lm.
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ferent steroids treatments, wemeasured prolactin (PRL)
secretion in spent media collected daily from gravity fed
co-cultures using ELISA. A continuous increase of PRL
over time was measured from stroma stimulated with
oestradiol and MPA compared to the stroma treated
only with oestradiol, which exhibited consistently low
production of PRL after 2 weeks of treatment (Fig. 7a).
An additional perfused device was treated with an
oestradiol + MPA and 8-Br-cAMP, a potent, intra-
cellular driver of stromal decidualization that is fre-
quently utilized for in vitro studies of progesterone
action in endometrial cells and cell lines.7 As expected,
we observed signiﬁcantly higher PRL production from
cultures exposed to 8-Br-cAMP, approximately one
order of magnitude higher after 4 days of treatment
(Fig. S4). These ﬁndings additionally demonstrate the
utility of our device to discriminate changes in the rate of
in vitro decidualization between cultures exposed to
MPA alone vs. culture exposed to MPA plus cAMP.
Discriminating among biological agents that impact
endometrial decidualization at the perivascular inter-
face will be important for future studies using our OoC
device to identify potential agents that inﬂuence pro-
gesterone action within the endometrium. Importantly,
our results equally demonstrate the capability of the
model to mimic each phase of a full 28-day menstrual
cycle, with continuous sampling capabilities for quan-
titative biochemical analysis.
DISCUSSION
In this work, a novel resin based high-resolution
porous membrane was used to design and fabricate a
FIGURE 5. Wall shear stress induces polarization of endothelial cells inside the device. (a) Without shear stress, cells showed a
non-directional and disorganized cytoskeleton. (b) In the presence of flow, cells elongated and aligned with the flow (from left to
right). Right panels show ZO-1 (green) and F-actin filaments staining (green with blue nuclei stained in blue for contrast) in the two
conditions (Bright field images at 340, fluorescent images at 3100).
FIGURE 6. Permeability coefficient of membrane in two-chamber platform calculated using macromolecule diffusion (FITC-
dextran) shows endothelial cells making a tight barrier, (p 5 0.0098).
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dual-chamber microﬂuidic model. The porous part of
this thin membrane is macroscopically translucent
which represents a favourable aspect in the assembly
and alignment stages of the microﬂuidic chambers
impressed in the PDMS layers. Moreover, being that
the remainder of the membrane is not porous, bonding
by plasma activation is optimized and leakage is pre-
vented. This unique membrane represents an interest-
ing alternative to opaque polycarbonate etched
membranes, thicker PDMS based membranes26 or
more fragile vitriﬁed membranes.36
We adopted the microﬂuidic approach to develop a
novel, physiologically relevant, OoC model of the
endometrial perivascular stroma.Within our model, for
the ﬁrst time to our knowledge, primary human
endothelial and endometrial stromal cells were co-cul-
tured in communicating chambers and maintained for
28 days, spanning the physiological human menstrual
cycle duration. Our OoC model will provide an in vivo-
like human model that avoids the expense of primate
models or the use of small animal models that are often
biologically distinct and less clinically relevant.42
Biological responses to endocrine signalling were
examined in this paper by mimicking the oestrogen and
progesterone changes that accompany the transition
from proliferative to secretory phase in vivo. We
measured the functional capability of the perivascular
stroma to undergo decidualization. Early evidence of
stromal/decidual transformation was observed after
10 days of combined oestrogen and progestin treat-
ment in the OoC. This transformation can be utilized
in future studies by us or others as an established
marker of endometrial viability under controlled con-
ditions. Clinically, our OoC model may also have rel-
evance since similar histological changes have been
observed in vivo after hormone therapy for prevention
of post-menopausal morbidity or treatment of
endometrial hyperplasia and carcinoma.12
Importantly, this co-culture system allows simulta-
neous analysis of both stromal decidualization and
endometrial vascular function under controlled physi-
ological conditions, such as endothelial cells remod-
elling and vascular barrier formation. The device
provides suﬃcient sensitivity for assessment of bio-
chemical changes that also reﬂect phenotypic changes.
Together, these ﬁndings validate the ability of the
microﬂuidic model to recapitulate and examine a
physiological reproductive process. These experiments
position our model as a novel method to determine the
normal homeostatic function of the vascular system in
the endometrium under hormonal regulation. While
beyond the scope of this report, the model can subse-
quently be used by us and others to begin to dissect key
elements of endothelial-stromal crosstalk and the im-
pact of this communication on inﬂammation and dis-
ease-related reproductive processes such as
endometriosis.38 In this regard, our OoC model as
designed to control perfusion of the endothelial com-
partment and eventually allow the introduction of
immune cells into the microﬂuidic co-culture device to
establish a model of peripheral leukocyte recruitment
into the endometrium. Speciﬁcally, in the absence of
pregnancy, ovarian progesterone levels decline, trig-
gering a local inﬂammatory response involving a vast
FIGURE 7. Validation of physiological response of the perivascular stroma to endocrine cues. (a) Schematic of the experimental
design of the co-culture device. (b) Bright field image of co-culture with stromal cells directly cultured with oestradiol (E2) alone for
14 days. (c) Schematic of the stimulation settings of the co-culture device with E2 and MPA with the corresponding changes of
morphology for the stroma from fibroblast-like to cuboidal shape, characteristic of the decidualized cells. (d) Bright field image
with stroma cells cultured with E2 + MPA for additional 14 days shows morphological changes (310). (e) Prolactin (PRL) pro-
duction measured by ELISA increases over time under the influence of E2 + MPA, but not when cultured with E2 only (p< 0.05).
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inﬁltration of leukocytes, release of cytokines, and
activation of matrix metalloproteinases.27 The vascular
endothelium act as the interface between peripheral
circulating immune cells and endometrial tissue. Hence
the loss of anti-inﬂammatory action of progesterone
during the latter part of the secretory phase is both
directly and indirectly linked to phenotypic changes
within the endothelium that affect immune cell
migration.34,43 Thus our OoC model is compatible for
future studies of cell interaction during menstruation
and in inﬂammatory endometrial diseases (i.e. stroma,
endothelial and leukocytes).
Noteworthy, PDMS has an ability to absorb
hydrophobicmolecules, speciﬁcally hormones.However,
until materials with improved absorption behaviour
become available, PDMS remains the most commonly
used and accepted material for prototyping biomedical
microfabrication technologies. The presented results
replicate previous observations in traditional in vitro
polystyrene culture dishes in terms of hormone respon-
sive biochemical and morphological decidualization,
suggesting that absorption of steroids by the membrane
was not an impediment to cellular response.
Modelling the human endometrial microenviron-
ment at the immuno-endocrine inﬂammatory axis oﬀers
the capability to better understand complex biological
and pathogenic factors that act to support or disrupt
endometrial function. Since decidualization is a critical
process for embryo implantation, the ability to explore
the earliest stages of decidualization will provide a un-
ique screening tool for fertility studies. Finally, our OoC
model of the endometrial perivascular stroma lends it-
self for the screening of pharmaceutical agents or envi-
ronmental toxicants that may alter reproductive health
or promote reproductive dysfunctions.
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